Conduit Pharmaceuticals Inc. (CDT)

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$0.21

-0.03 (-12.92%)

Market Cap: $269,880

Last updated: Oct 16, 2026 at 1:54 PM ET

Earnings

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26 Reported Jul 2, 2026Reported Jul 2	$-8.71	N/A	-	N/A	Beat	-	-	-59.4%
Mar 31, 2026Mar 26 Reported Apr 3, 2026Reported Apr 3	$-99.99	N/A	-	N/A	Beat	-	-	-7475.0%
Dec 31, 2025Dec 25 Reported Dec 31, 2025Reported Dec 31	$-57860.32	N/A	-	N/A	Beat	-	-	-2691077.7%
Sep 30, 2025Sep 25 Reported Nov 13, 2025Reported Nov 13	$-13.16	N/A	-	N/A	Beat	-	-	+100.0%
Jun 30, 2025Jun 25 Reported Aug 14, 2025Reported Aug 14	$-5.46	N/A	-	N/A	Beat	-	-	+100.0%
Mar 31, 2025Mar 25 Reported May 15, 2025Reported May 15	$-1.32	N/A	-	N/A	Beat	-	-	+100.0%
Dec 31, 2024Dec 24 Reported Mar 28, 2025Reported Mar 28	$-2.15	N/A	-	N/A	Beat	-	-	+100.0%
Sep 30, 2024Sep 24 Reported Nov 14, 2024Reported Nov 14	$-1000000.00	N/A	-	N/A	Beat	-	-	-334.4%
Jun 30, 2024Jun 24 Reported Aug 12, 2024Reported Aug 12	$-1000000.00	N/A	-	N/A	Beat	-	-	+0.0%
Mar 31, 2024Mar 24 Reported Apr 1, 2024Reported Apr 1	$-1000000.00	N/A	-	N/A	Beat	-	-	-200.0%
Dec 31, 2023Dec 23 Reported Dec 31, 2023Reported Dec 31	$-1000000.00	N/A	-	N/A	Beat	-	-	-3333333433.0%
Sep 30, 2023Sep 23 Reported Nov 20, 2023Reported Nov 20	$-230218.76	N/A	-	N/A	Beat	-	-	-2302187745.0%
Jun 30, 2023Jun 23 Reported Aug 14, 2023Reported Aug 14	$-1000000.00	N/A	-	N/A	Beat	-	-	-9999999899.0%
Mar 31, 2023Mar 23 Reported May 15, 2023Reported May 15	$1000000.00	N/A	-	N/A	Beat	-	-	+5000000099.5%
Dec 31, 2022Dec 22 Reported Mar 28, 2023Reported Mar 28	$0.03	$0.00	-	N/A	Beat	-	-	-
Sep 30, 2022Sep 22 Reported Nov 7, 2022Reported Nov 7	$0.01	$0.00	-	N/A	Beat	-	-	-
Jun 30, 2022Jun 22 Reported Aug 11, 2022Reported Aug 11	$-0.01	$0.00	-	N/A	Miss	-	-	-
Mar 31, 2022Mar 22 Reported May 17, 2022Reported May 17	$-0.02	$0.00	-	N/A	Miss	-	-	-

Key Metrics

Valuation
P/E Ratio	-0.00	EV/EBITDA	N/A
Price/FCF	-0.09x	FCF Yield	-1161.61%
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-69.70%	ROIC	N/A
Financial Health
Debt/Equity	N/A	Interest Coverage	3.24x
Current Ratio	2.14x	Quick Ratio	1.49x
Trading Statistics
Beta	1.56	Avg Volume	6.84M
52-Week High	$23437.50	52-Week Low	$0.20

Technical Indicators Dashboard

Moving Averages

SMA 10$0.68

SMA 20$1.64

SMA 50$27.78

SMA 200$2036.66

EMA 10$0.92

EMA 20$4.58

EMA 50$57.13

EMA 200$22907.63

MACD

Line: -7.33Signal: -9.58Hist: 2.25

ADX

ADX: 27.5+DI: 0.6-DI: 0.9

Aroon & PSAR

Aroon Up52.0

Aroon Down48.0

PSAR$1.85

Bollinger Bands

Upper Band$4.21

Lower Band$-0.92

%B Position31254%(Upper)

Band Width0.22

RSI (14-Day)

Oversold

15.1

Momentum Oscillators

Stoch %K12.7

Stoch %D21.2

Williams %R-92.3

ROC (10d)-83.3%

Momentum-1.04

CCI (20d)-152.3

MFI (14d)2.9

Volatility Measures

ATR (14d)$9.49(4538.7%)

StdDev (20d)1.28

Hist Vol189.4%(High)

Volume Flow

VWAP$0.20

OBV232.8M

AD Line575576.1B

CMF (20d)342.828

Volume Metrics

Avg Vol (20d)7.1M

Vol Ratio0.3x(Low)

VWMA (20d)$2.29

Pivot Points

R3$0.32

R2$0.29

R1$0.26

Pivot Point$0.23

S1$0.21

S2$0.17

S3$0.15

Advanced Oscillators

TSI-70.01

Ultimate Osc39.1

KST-916.49

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$750.16M	$696.38M	$2.72B	$698.22M	$671.99M	$624.86M	$1.08B	$654.93M	$-1,345,343,000	$535.67M	$0	$0
Cost of Revenue	$449.13M	$438.29M	$515,000	$885,000	$828,000	$190,000	$452,000	$5,000	$377.53M	$334.08M	N/A	N/A
Gross Profit	$301.03M	$258.09M	$-515,000	$-885,000	$-828,000	$-190,000	$-452,000	$-5,000	$-695,873,000	$201.60M	N/A	N/A

Operating Expenses	$183.66M	$180.13M	$21.16M	$7.03M	$4.95M	$3.62M	$3.51M	$5.81M	$3.14M	$2.96M	$895,000	$430,000
R&D	$32.91M	$30.09M	$746,000	$1.53M	$1.86M	$916,000	$132,000	$3.09M	$25,000	$128,000	$90,000	$0
SG&A	$2.70M	$138.65M	$20.41M	$5.50M	$3.09M	$2.70M	$3.38M	$2.72M	$3.12M	$2.83M	$805,000	$430,000
Operating Income	$117.37M	$77.96M	$-21,156,000	$-7,033,000	$-4,952,000	$-3,616,000	$-3,513,000	$-5,811,000	$-3,140,000	$-2,955,000	$-895,000	$-430,000

Interest Income	$0	$0	$9,000	$7,000	$4,000	$8,000	$2,000	$8,000	$2,000	$9,000	$0	$0
Interest Expense	$40.52M	$13.46M	$38,000	$48,000	$57,000	$176,000	$960,000	$310,000	$119,000	$119,000	$330,000	$47,000
Income Before Tax	$85.20M	$62.77M	$-21,325,000	$-7,118,000	$-6,028,000	$-4,753,000	$-2,406,000	$-6,461,000	$-5,383,000	$-3,552,000	$1.78M	$2.63M
Income Tax Expense	$16.67M	$11.74M	$29.44M	$-97,000	$-5,666,000	$-10,144,000	$10,000	$-60,153,000	$-11,091,000	$-8,360,000	$300,000	$47,000

Net Income	$68.54M	$51.03M	$-21,325,000	$-7,118,000	$-6,028,000	$-4,753,000	$-2,406,000	$-6,461,000	$-5,383,000	$-3,552,000	$1.78M	$2.63M

EBITDA	$127.67M	$108.69M	$-18,878,000	$-6,185,000	$-5,143,000	$-4,380,000	$-994,000	$-6,146,000	$18.25M	$-3,433,000	$1.90M	$2.63M
EBIT	$127.20M	$76.23M	$-21,287,000	$-7,070,000	$-5,971,000	$-4,577,000	$-1,446,000	$-6,151,000	$-5,264,000	$-29,942,000	$1.86M	$2.03M

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about CDT

News

CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset

CDT Equity Inc. (Nasdaq: CDT) announced that Sarborg Limited, in which CDT is a significant shareholder, has filed a new patent application for novel solid forms of a major...

FinancialContent•Oct 14, 2026 8:11 AM ET10/14/26•Bullish

A respiratory medicine yielded unexpected new forms. Sarborg filed a patent application.

CDT Equity Inc. highlighted Sarborg's patent application for new solid forms of a respiratory medicine, which expands Sarborg's intellectual property and offers potential for new formulations and indications. CDT holds...

Stock Titan•Oct 14, 2026 8:11 AM ET10/14/26•Somewhat-Bullish

CDT Equity - Note Maturing March 24, 2027 Pay

This article concerns a CDT Equity note that is scheduled to mature on March 24, 2027, and outlines its payment details. It specifies that the maturity payment for this particular note will occur on the aforementioned...

Moomoo•Oct 14, 2026 2:43 AM ET10/14/26•Neutral

CDT Equity Announces $6.75 Million Senior Secured Convertible Note Issuance to J.J. Astor & Co.

CDT Equity Inc. has announced the issuance of a $6.75 million senior secured convertible promissory note to J.J. Astor & Co. The note, maturing on March 24, 2027, will be funded in two tranches...

Kalkine Media•Oct 13, 2026 7:41 AM ET10/13/26•Neutral

CDT Equity Secures $6.75 Million Secured Convertible Note; Issues 225,000 Warrants to J.J. Astor

CDT Equity has secured a $6.75 million senior secured convertible note from J.J. Astor to enhance its liquidity and fund operations. In connection with this financing...

TradingView•Oct 13, 2026 7:41 AM ET10/13/26•Somewhat-Bullish

CDT Valuation and Fair Value

P/E: -0.0x
P/FCF: -0.1x
P/B: 0.0x

See GNG's fair value

CDT Profitability: Margins, ROIC and FCF

Gross margin: 11.5%
Operating margin: 0.0%
Net margin: 0.0%
ROE: -69.7%
FCF margin: -0.0%
FCF yield: -1161.6%

CDT Competitors

Company	Ticker
Catheter Precision Inc.	VTAK
Humacyte Inc	HUMAW
Vicarious Surgical Inc.	RBOT
Scworx Corp	WORX
Safeplus International Holdings Limited	BIPH
ProPhase Labs Inc	PRPH
Inotiv Inc	NOTV
China SXT Pharmaceuticals Inc	SXTC

Sector: Healthcare

CDT Earnings: Beat Rate and Next Report

Beat rate: 2 of 4 quarters (50.0%)

Frequently Asked Questions About CDT

Does CDT pay dividends?

Conduit Pharmaceuticals Inc. (CDT) does not currently pay a regular dividend.

What is CDT's market cap?

Conduit Pharmaceuticals Inc. (CDT) has a market capitalization of $269,880 with a current stock price of $0.21.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In